Hdc Medical, Inc. v. Minntech Corporation

474 F.3d 543, 2007 U.S. App. LEXIS 1618, 2007 WL 174398
CourtCourt of Appeals for the Eighth Circuit
DecidedJanuary 25, 2007
Docket06-1638
StatusPublished
Cited by37 cases

This text of 474 F.3d 543 (Hdc Medical, Inc. v. Minntech Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hdc Medical, Inc. v. Minntech Corporation, 474 F.3d 543, 2007 U.S. App. LEXIS 1618, 2007 WL 174398 (8th Cir. 2007).

Opinion

SMITH, Circuit Judge.

HDC Medical, Inc (“HDC”) and Minn-tech Corporation (“Minntech”) are competitors in a specialized medical-device market. HDC brought suit against Minntech alleging exclusionary and predatory conduct in violation of the Sherman Act. The district court 1 granted Minntech’s motion for summary judgment. HDC appeals. We affirm.

I. Background

Both HDC and Minntech manufacture dialyzer reprocessing machines. Minntech manufactures a dialyzer reprocessing machine called “the Renatron,” while HDC produces “the MAKY.” Dialyzer reprocessing machines work in conjunction with dia-lyzers. Dialyzers, which filter blood waste products, serve as an artificial kidney in hemodialysis. Dialyzers come in two forms: single-use and multiple-use. Single-use dialyzers are disposable and can be used only once. Multiple-use dialyzers, on the other hand, can be used repeatedly if cleaned by a dialyzer-reprocessing machine. Dialyzer reprocessing machines sanitize multiple-use dialyzers using chemical mixtures called reprocessing solutions. Minntech produces a reprocessing solution marketed as Renalin. HDC Medical also produces a reprocessing solution marketed as Peracidin.

Beginning in 2000, Minntech began modifying the design of the Renatron. These modifications, HDC alleges, rendered HDC’s reprocessing solution, Peracidin, incompatible with the Minntech dialyzer reprocessing machines, the Renatron. Additionally, these modifications, HDC alleges, were accompanied by Minntech warranty manipulations, slander of the HDC products and tying arrangements intended to push HDC out of the reprocessing solution market.

HDC sued Minntech, alleging' that Minntech’s actions violated the Sherman Act, 15 U.S.C. § § 1, 2. Minntech successfully moved for summary judgment and the case was dismissed. The district court dismissed HDC’s monopoly claim after determining no genuine issue of material fact existed regarding Minntech’s power in the relevant market. The district court also dismissed HDC’s attempted monopoly claim after determining that no genuine issue of material fact existed regarding Minntech’s alleged anticompetitive conduct or Minntech’s dangerous probability of success.

II. Discussion

“We review de novo a grant of summary judgment, considering the facts in the light most favorable to the nonmov-ing party. Summary judgment is proper when no genuine issues of material fact exist and the moving party is entitled to judgment as a matter of law.” Nat'l Am. Ins. Co. v. W&G, Inc., 439 F.3d 943, 945 (8th Cir.2006) (internal citations omitted). The courts should enter summary judgment on the merits in antitrust litigation sparingly. Lomar Wholesale Grocery, Inc. v. Dieter’s Gourmet Foods, Inc., 824 F.2d 582, 585 (8th Cir.1987). However, where there has been ample opportunity for discovery, summary judgment is appropriate in antitrust cases, just as in any other litigation, upon a showing of an ab *547 sence of any genuine issue of material fact. Willmar Poultry Co. v. Morton-Norwich Prods., Inc. 520 F.2d 289, 293 (8th Cir.1975).

A. Monopolization Claim

A prima facie claim of monopolization under the Sherman Act requires a plaintiff to show that the defendant “possessed monopoly power in the relevant market” and “willfully acquired.or maintained that power.” Amerinet, Inc. v. Xerox Corp., 972 F.2d 1483, 1490 (8th Cir.1992). To establish that a defendant possesses the requisite market power required for monopolization liability, a plaintiff must establish that the defendant has a dominant market share in a well-defined relevant market. Morgenstern v. Wilson, 29 F.3d 1291, 1296 (8th Cir.1994).

The relevant product market is a question of fact, which the plaintiff bears the burden of proving. Id. We have noted, “Antitrust claims often rise or fall on the definition of the relevant market.” Bathke v. Casey’s Gen. Stores, Inc., 64 F.3d 340, 345 (8th Cir.1995). The relevant market has two components — a product market and a geographic market. Id. Here, the parties dispute only the relevant product market. The district court found that single-use and multiple-use dialyzers are competitors in the same market and concluded that Minntech did not possess monopoly power in the relevant market. HDC, however, contends that single-use and multiple-use dialyzers do not compete in the same product market.

The boundaries of the product market can be determined by the reasonable interchangeability or cross-elasticity of demand between the product itself and possible substitutes for it. Brown Shoe Co. v. United States, 370 U.S. 294, 325, 82 S.Ct. 1502, 8 L.Ed.2d 510 (1962); United States v. Archer-Daniels-Midland Co., 866 F.2d 242, 246 (8th Cir.1988) cert. denied; 493 U.S. 809, 110 S.Ct. 51, 107 L.Ed.2d 20 (1989). In other words, the product market can be determined by analyzing how “consumers will shift from one product to the other in response to changes in their relative costs.” Super-Turf, Inc. v. Monsanto Co., 660 F.2d 1275, 1278 (8th Cir.1981). To conduct this inquiry, the courts must weigh several, factors including, industry or public recognition of the products as a separate economic entity, the product’s peculiar characteristics and uses, unique production facilities, distinct customers, distinct prices, sensitivity to price changes, and specialized vendors. Brown Shoe Co., 370 U.S. at 325, 82 S.Ct. 1502.

The district court granted Minntech’s motion for summary judgment after finding that multiple-use dialyzers and single-use dialyzers have identical uses. HDC does not dispute this finding but argues that the district court ignored case law suggesting that significant price differences between identical-use products can establish reasonable interchangeability, and thus support a jury’s inference that two separate product markets exist. We disagree.

The Supreme Court has repeatedly held that a price differential alone is insufficient to infer two separate product markets. “[Pjrice is only one factor in a user’s choice between one [product] or the other. That there are price differentials between the two products ... are relevant matters but not determinative of the product market issue.” United States v. Cont’l Can Co., 378 U.S. 441, 455, 84 S.Ct. 1738, 12 L.Ed.2d 953 (1964); see also Brown Shoe Co., 370 U.S.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

George Par v. Wolfe Clinic, P.C.
70 F.4th 441 (Eighth Circuit, 2023)
BCBSM, Inc. v. GS Labs, LLC
D. Minnesota, 2023
Pate v. Precythe
E.D. Missouri, 2022
Olson v. PowerBlock, Inc.
D. Minnesota, 2022
Rozo v. Principal Life Ins. Co.
344 F. Supp. 3d 1025 (S.D. Iowa, 2018)
Park Irmat Drug Corp. v. Express Scripts Holding Co.
310 F. Supp. 3d 1002 (E.D. Missouri, 2018)
Mahaska Bottling Co. v. PepsiCo Inc.
271 F. Supp. 3d 1054 (S.D. Iowa, 2017)
Salah v. Diamond Crystal Brands, Inc.
241 F. Supp. 3d 893 (S.D. Iowa, 2016)
Keokuk Glycerin, LLC v. Midwest Laboratories, Inc.
241 F. Supp. 3d 887 (S.D. Iowa, 2016)
Phoenix Insurance v. Infogroup, Inc.
147 F. Supp. 3d 815 (S.D. Iowa, 2015)
Lenox MacLaren Surgical Corp. v. Medtronic, Inc.
762 F.3d 1114 (Tenth Circuit, 2014)
DeLuca's Market Corp. v. SuperValu, Inc.
752 F.3d 728 (Eighth Circuit, 2014)
D&G, Inc. v. SuperValu, Inc.
Eighth Circuit, 2014
Barucic v. Titan Tire Corp.
839 F. Supp. 2d 1038 (S.D. Iowa, 2012)
Federal Trade Commission v. Lundbeck, Inc.
650 F.3d 1236 (Eighth Circuit, 2011)
Southeast Missouri Hosp. v. CR Bard, Inc.
616 F.3d 888 (Eighth Circuit, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
474 F.3d 543, 2007 U.S. App. LEXIS 1618, 2007 WL 174398, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hdc-medical-inc-v-minntech-corporation-ca8-2007.